🇺🇸 FDA
Patent

US 9464125

Engineered potent cytotoxic stapled BH3 peptides

granted A61KA61K31/635A61K38/00

Quick answer

US patent 9464125 (Engineered potent cytotoxic stapled BH3 peptides) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/635, A61K38/00, A61K38/10, A61K38/12